Skip to main content
    D

    Dolby Laboratories (DLB)

    Official site

    INDUSTRIALS • SPECIALTY BUSINESS SERVICES • NYSE

    $61.16
    -2.46 (-3.86%)

    Market Cap: $5.96B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Dolby Laboratories (DLB) Financials: Revenue, Profit and Cash Flow

    Updated Jul 30, 2026. Financial statements from company filings, amounts in US dollars.

    Dolby Laboratories reported revenue of $1.35B for the fiscal year ended Sep 30, 2025, up 5.9% from the year before. That year, net income was $256.49M with a net margin of 19.0%, operating cash flow was $472.20M and free cash flow was $435.85M. The quarter ended Jun 30, 2026 had revenue of $305.00M and net income of $29.21M.

    Revenue and Margins

    The operating margin was 19.6% in the fiscal year ended Sep 2025. Over the 9 years to Sep 2025, revenue grew from $1.03B, a compound annual rate of 3.1%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Sep 2025$1.35B+5.9%88.1%19.6%19.0%
    Sep 2024$1.27B-2.0%89.0%20.3%20.8%
    Sep 2023$1.30B+3.7%88.3%16.6%15.5%
    Sep 2022$1.25B-2.1%88.7%16.5%14.7%
    Sep 2021$1.28B+10.3%89.9%26.9%24.8%
    Sep 2020$1.16B-6.4%87.4%18.8%19.9%
    Sep 2019$1.24B-41.1%87.0%20.7%20.6%
    Sep 2018$2.11B-2.4%87.9%8.7%2.0%
    Sep 2017$2.16B+110.6%89.0%11.4%9.6%
    Sep 2016$1.03BN/A89.4%22.6%18.2%
    Annual, fiscal years ended Sep 2016 to Sep 2025

    Income Statement

    In the fiscal year ended Sep 2025, net income fell 3.0% from the year before. In the quarter ended Jun 2026, net income fell 37.2% from the same quarter a year earlier.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018Sep 2017Sep 2016
    Revenue$1.35B$1.27B$1.30B$1.25B$1.28B$1.16B$1.24B$2.11B$2.16B$1.03B
    Cost of revenue$160.13M$140.50M$152.57M$141.36M$130.03M$146.50M$160.85M$255.12M$237.06M$108.98M
    Gross profit$1.19B$1.13B$1.15B$1.11B$1.15B$1.02B$1.08B$1.85B$1.92B$916.76M
    Research and development$261.79M$263.66M$271.52M$261.17M$253.64M$239.04M$237.87M$236.79M$233.31M$219.61M
    Operating income$264.96M$258.33M$215.75M$206.60M$344.39M$218.74M$257.08M$183.50M$247.13M$231.79M
    Net income$256.49M$264.32M$201.64M$183.90M$317.82M$231.62M$255.50M$42.30M$207.11M$186.40M
    EBITDA$386.71M$362.81M$316.62M$314.15M$465.63M$339.86M$343.04M$261.36M$332.76M$319.32M
    Fiscal years ended Sep 2016 to Sep 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Revenue$305.00M$395.63M$346.71M$307.02M$315.55M$369.56M$357.00M$304.81M$288.82M$364.52M$315.57M$290.56M
    Gross profit$264.68M$350.90M$303.50M$267.50M$271.54M$333.72M$316.23M$270.81M$253.16M$325.75M$283.51M$255.01M
    Operating income$34.32M$112.95M$62.16M$29.68M$47.64M$107.76M$79.88M$46.35M$36.78M$108.97M$66.22M-$3.49M
    Net income$29.21M$95.45M$53.68M$49.65M$46.54M$92.23M$68.07M$58.87M$39.66M$98.21M$67.58M$9.91M
    Last 12 quarters

    Balance Sheet

    As of Sep 2025, cash and equivalents exceeded short-term debt of $10.38M by $691.51M.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018Sep 2017Sep 2016
    Total assets$3.23B$3.11B$2.98B$2.69B$3.11B$2.92B$2.82B$2.87B$2.53B$2.31B
    Current assets$1.39B$1.19B$1.49B$1.31B$1.76B$1.55B$1.38B$1.50B$1.01B$759.73M
    Cash and equivalents$701.89M$482.05M$745.36M$620.13M$1.23B$1.07B$797.21M$918.06M$627.02M$516.11M
    Total liabilities$595.81M$623.03M$607.58M$438.53M$501.45M$478.92M$508.72M$494.88M$389.71M$331.37M
    Short-term debt$10.38M$12.24M$13.63M$13.26M$15.40M$15.82M$0$0$0$0
    Shareholder equity$2.62B$2.48B$2.36B$2.25B$2.60B$2.43B$2.31B$2.36B$2.14B$1.97B
    Fiscal years ended Sep 2016 to Sep 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$3.16B$3.25B$3.19B$3.23B$3.20B$3.23B$3.16B$3.13B$2.97B$3.04B$2.94B$2.99B
    Total liabilities$563.89M$622.36M$589.25M$595.81M$581.75M$646.02M$641.57M$643.72M$526.20M$607.04M$573.22M$622.38M
    Cash and equivalents$669.39M$594.28M$643.85M$701.89M$698.57M$626.55M$520.82M$577.75M$741.64M$709.53M$656.82M$817.97M
    Shareholder equity$2.58B$2.62B$2.59B$2.62B$2.60B$2.57B$2.51B$2.48B$2.43B$2.42B$2.35B$2.36B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Sep 2025, free cash flow was 92.3% of operating cash flow. Dividends and share repurchases together came to 66.8% of it.

    Annual

    Line itemSep 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018Sep 2017Sep 2016
    Operating cash flow$472.20M$327.25M$367.08M$318.58M$447.75M$343.85M$327.67M$352.20M$377.79M$360.06M
    Capital expenditures$36.35M$30.01M$30.34M$47.93M$54.45M$66.35M$96.28M$72.81M$99.62M$100.76M
    Free cash flow$435.85M$297.25M$336.74M$270.65M$393.30M$277.50M$231.39M$279.39M$278.18M$259.30M
    Dividends paid$128.45M$129.66M$103.67M$101.50M$96.53M$88.86M$78.51M$67.18M$59.15M$48.61M
    Share repurchases$162.49M$199.08M$180.42M$566.90M$278.07M$196.81M$363.37M$172.61M$117.68M$114.49M
    Investing cash flow-$10.59M-$286.29M$54.21M-$295.94M-$44.91M$134.37M-$56.23M$78.09M-$158.03M-$282.50M
    Financing cash flow-$247.24M-$287.81M-$236.81M-$610.56M-$252.51M-$207.78M-$385.28M-$133.63M-$106.83M-$91.99M
    Fiscal years ended Sep 2016 to Sep 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flow$167.46M$92.51M$54.80M$122.83M$67.69M$174.90M$106.78M$116.17M$21.26M$181.41M$8.41M$85.02M
    Capital expenditures$14.99M$9.06M$4.63M$16.24M$6.43M$6.90M$6.78M$7.38M$7.61M$8.92M$6.10M$8.19M
    Free cash flow$152.47M$83.44M$50.17M$106.59M$61.26M$168.00M$100.00M$108.79M$13.65M$172.49M$2.31M$76.83M
    Last 12 quarters

    Frequently Asked Questions About DLB

    What is Dolby Laboratories' annual revenue?

    Dolby Laboratories reported revenue of $1.35B for the fiscal year ended Sep 30, 2025.

    How fast is Dolby Laboratories' revenue growing?

    Revenue was up 5.9% for the fiscal year ended Sep 30, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 2.5%.

    Is Dolby Laboratories profitable?

    Yes. Dolby Laboratories reported net income of $256.49M for the fiscal year ended Sep 30, 2025, with a net margin of 19.0%.

    How much free cash flow does DLB generate?

    For the fiscal year ended Sep 30, 2025, operating cash flow of $472.20M minus capital expenditures of $36.35M produced free cash flow of $435.85M.

    How much debt does Dolby Laboratories have?

    The balance sheet dated Sep 30, 2025 reported short-term debt of $10.38M and cash and equivalents of $701.89M.